{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:39:57Z","timestamp":1791189597354,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.vaccine.2010.04.085","type":"journal-article","created":{"date-parts":[[2010,5,13]],"date-time":"2010-05-13T20:41:11Z","timestamp":1273783271000},"page":"4581-4587","source":"Crossref","is-referenced-by-count":118,"title":["Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep"],"prefix":"10.1016","volume":"28","author":[{"given":"Baptiste","family":"Dungu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Louw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Lubisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate F.","family":"von Teichman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Bouloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.04.085_bib1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/path.1700340418","article-title":"Enzootic hepatitis or Rift Valley fever. An undescribed virus disease of sheep, cattle and man from East Africa","volume":"34","author":"Daubney","year":"1931","journal-title":"J Pathol Bacteriol"},{"key":"10.1016\/j.vaccine.2010.04.085_bib2","series-title":"Infectious diseases of livestock","first-page":"1037","article-title":"Rift Valley fever","author":"Swanepoel","year":"2004"},{"key":"10.1016\/j.vaccine.2010.04.085_bib3","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3201\/eid0812.020195","article-title":"Genetic analysis of viruses associated with emergence of Rift Valley fever in Saudi Arabia and Yemen. 2000\u201301","volume":"8","author":"Shoemaker","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2010.04.085_bib4","first-page":"73","article-title":"Rift Valley fever outbreak \u2013 Kenya, November 2006\u2013January 2007","volume":"56","author":"Centers for Disease Control and Prevention (CDC)","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2010.04.085_bib5","unstructured":"EMPRES, FAO. Rift Valley fever outbreaks in Madagascar and potential risks to neighboring countries, <http:\/\/www.fao.org\/docs\/eims\/upload\/\/242253\/EW_rvf_apr08.pdf>; 2008 [accessed 15.08.08]."},{"key":"10.1016\/j.vaccine.2010.04.085_bib6","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/0042-6822(91)90087-R","article-title":"Sequences and coding strategies of the S RNAs of Toscana and Rift Valley fever viruses compared to those of Punta Toro, Sicilian Sandfly fever, and Uukuniemi viruses","volume":"180","author":"Giorgi","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2010.04.085_bib7","first-page":"1","article-title":"Rift Valley fever: the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine","volume":"30","author":"Smithburn","year":"1949","journal-title":"Br J Exp Pathol"},{"key":"10.1016\/j.vaccine.2010.04.085_bib8","first-page":"11","article-title":"The pathology of Rift Valley fever. II. Lesions occurring in field cases in adult cattle, calves and aborted foetuses","volume":"49","author":"Coetzer","year":"1982","journal-title":"Onderstepoort J Vet Res"},{"key":"10.1016\/j.vaccine.2010.04.085_bib9","first-page":"155","article-title":"Rift Valley fever vaccine \u2013 antibody and immune response in cattle to a live and an inactivated vaccine","volume":"50","author":"Barnard","year":"1979","journal-title":"J S Afr Vet Assoc"},{"key":"10.1016\/j.vaccine.2010.04.085_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0034-5288(18)34598-3","article-title":"Experimental infection of cattle with pantropic Rift Valley fever virus","volume":"8","author":"Coackley","year":"1967","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2010.04.085_bib11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2460\/ajvr.1991.52.01.50","article-title":"Ability of a mutagenized virus variant to protect young lambs from Rift Valley fever","volume":"52","author":"Hubbard","year":"1991","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2010.04.085_bib12","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.2460\/ajvr.1987.48.07.1042","article-title":"Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes","volume":"48","author":"Morrill","year":"1987","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2010.04.085_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0264-410X(91)90314-V","article-title":"Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep","volume":"9","author":"Morrill","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.04.085_bib14","first-page":"95","article-title":"Teratogenicity of a mutagenized Rift Valley fever virus (MVP12) in sheep","volume":"69","author":"Hunter","year":"2001","journal-title":"Onderstepoort J Vet Res"},{"key":"10.1016\/j.vaccine.2010.04.085_bib15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.1995.53.405","article-title":"Characterization of Clone 13, a naturally attenuated avirulent isolate of RVF virus, which is altered in the small segment","volume":"53","author":"Muller","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2010.04.085_bib16","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1128\/JVI.74.3.1538-1543.2000","article-title":"The S segment of Rift Valley fever Phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice","volume":"74","author":"Vialat","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.04.085_bib17","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1128\/AEM.15.3.594-596.1967","article-title":"Effect of virus multiplicity and TC concentration on growth of RVF virus","volume":"15","author":"Orlando","year":"1967","journal-title":"Appl Microbiol"},{"key":"10.1016\/j.vaccine.2010.04.085_bib18","series-title":"Virology. A laboratory manual","author":"Burleson","year":"1992"},{"key":"10.1016\/j.vaccine.2010.04.085_bib19","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1099\/0022-1317-77-12-3053","article-title":"Persistent infection of mammalian cells by Rift Valley fever virus","volume":"77","author":"Billecocq","year":"1996","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2010.04.085_bib20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0264-410X(99)00218-2","article-title":"Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience","volume":"18","author":"Pittman","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.04.085_bib21","first-page":"297","article-title":"Perinatal mortality in lambs of ewes exposed to cultures of Diplodia maydis during gestation","volume":"58","author":"Kellerman","year":"1991","journal-title":"Onderstepoort J Vet Res"},{"key":"10.1016\/j.vaccine.2010.04.085_bib22","first-page":"323","article-title":"Rift Valley fever","volume":"vol. 1","author":"OIE","year":"2009"},{"key":"10.1016\/j.vaccine.2010.04.085_bib23","first-page":"341","article-title":"Distribution of viral antigen in tissues of new-born lambs infected with Rift Valley fever virus","volume":"63","author":"Van der Lugt","year":"1996","journal-title":"Onderstepoort J Vet Res"},{"key":"10.1016\/j.vaccine.2010.04.085_bib24","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jmv.20624","article-title":"Adverse response of non-indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine","volume":"78","author":"Botros","year":"2006","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2010.04.085_bib25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/vr.109.17.383","article-title":"Abortion in vaccinated sheep and cattle after challenge with Rift Valley fever virus","volume":"109","author":"Yedloutschnig","year":"1981","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2010.04.085_bib26","first-page":"119","article-title":"Hydrops amnii in sheep associated with hydraencephaly and arthrogryposis with Wesselsbron and Rift Valley fever viruses as aetiological agents","volume":"44","author":"Coetzer","year":"1977","journal-title":"Onderstepoort J Vet Res"},{"key":"10.1016\/j.vaccine.2010.04.085_bib27","doi-asserted-by":"crossref","unstructured":"Davies FG. Rift Valley fever in Kenya. 49th session of OIE Paris, May 1981.","DOI":"10.1007\/978-94-011-9034-3_12"},{"key":"10.1016\/j.vaccine.2010.04.085_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0166-3542(86)90024-0","article-title":"Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator","volume":"6","author":"Peters","year":"1986","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2010.04.085_bib29","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.2460\/ajvr.1980.41.10.1559","article-title":"Evaluation of a formalin-inactivated Rift valley fever vaccine in sheep","volume":"41","author":"Harrington","year":"1980","journal-title":"Am J Vet Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10006213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10006213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T21:29:41Z","timestamp":1740086981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10006213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":29,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0264410X10006213"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.04.085","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}